“The Functional Endoscopic Sinus Surgery Market Size was valued at USD 1.01 Billion in 2023 and is expected to reach USD 1.91 Billion by 2032 and grow at a CAGR of 7.66% over the forecast period ...

Findings seen among patients with chronic rhinosinusitis with nasal polyps and obesity. HealthDay News — Use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with reduced ...

In 1978, Messerklinger [2] documented the first systematic and detailed description of endoscopic findings of the sino-nasal cavity. The work of these investigators consisted of detailed endoscopic ...

Following functional endoscopic sinus surgery, adults with chronic rhinosinusitis with nasal polyps and obesity had a lower risk for revision surgery if they were prescribed a GLP-1 receptor agonist, ...

This new study, which followed patients up to 6 months after functional endoscopic sinus surgery, evaluated results using objective and subjective measures. “Nasal polyps are associated with ...

Sinusitis is one of the most common chronic health problems in the U.S., afflicting 37 million Americans each year. Dr. Caroline Yoon, a board certified Ear, Nose and Throat surgeon, states “Patients ...

Minimally invasive surgery to alleviate the pain and pressure of sinusitis is a safe, effective therapy for geriatric patients who can't be helped by medication alone, according to new research.

Dubai - February 27 th 2006: Under the patronage of H.E. Qadhi Saeed Al Murooshid, Director General of the Department of Health and Medical Services (DOHMS), the first 'International Course on ...

Sinusitis primarily requires medical management. However, those cases that are refractory to medical therapy are excellent candidates for functional endoscopic sinus surgery (FESS). Appropriate ...